IL-1β derived from mixed-polarized macrophages activates fibroblasts and synergistically forms a cancer-promoting microenvironment-Reference-Cited by-同舟云学术

IL-1β derived from mixed-polarized macrophages activates fibroblasts and synergistically forms a cancer-promoting microenvironment

Published:2022-12-13 Issue:2 Volume:26 Page:187-202
ISSN:1436-3291
Container-title:Gastric Cancer
language:en
Short-container-title:Gastric Cancer

Author:

Zhang Jun,Fu Lingfeng,Yasuda-Yoshihara Noriko,Yonemura Atsuko,Wei Feng,Bu Luke,Hu Xichen,Akiyama Takahiko,Kitamura Fumimasa,Yasuda Tadahito,Semba Takashi,Uchihara Tomoyuki,Itoyama Rumi,Yamashita Kohei,Eto Kojiro,Iwagami Shiro,Yashiro Masakazu,Komohara Yoshihiro,Baba Hideo^ORCID,Ishimoto Takatsugu^ORCID

Funder

Japan Society for the Promotion of Science London

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Gastroenterology,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10120-022-01352-3.pdf

Reference44 articles.

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30.

2. Ding N, Zou Z, Sha H, et al. iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer. Nat Commun. 2019;10(1):1336.

3. Kang YK, Boku N, Satoh T, et al. Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2017;390(10111):2461–71.